<DOC>
	<DOCNO>NCT01083719</DOCNO>
	<brief_summary>HYPOTHESIS AND SAMPLE SIZE The tumor delineate FDG-PET significantly different delineation achieve MR T1 contrast weight image glioblastoma ; expect standard error 12.5 % ( confidence interval 25 % ) , confidence level set 95 % , sample size 15 patient would accrue study .</brief_summary>
	<brief_title>A Comparison FDG-PET Versus MRI Based Target Volume Delineation Glioblastoma Role FDG-PET/CT Alteration MRI Based Target Volumes .</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>1 . Post operative patient document high grade glioma ( grade III IV ) 2 . Patients undergone previous irradiation brain . 3 . Performance Scale define ECOG PS 03 1 . Patients diabetic . 2 . Patients pregnant . 3 . Any documented contrast allergy agent use image . 4 . Patients unable comprehend cooperate effectively treatment planning .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Glioblastoma</keyword>
	<keyword>FDG-PET</keyword>
	<keyword>MRI</keyword>
</DOC>